PDT Partners LLC Raises Stock Position in Humana Inc. (NYSE:HUM)

PDT Partners LLC lifted its position in Humana Inc. (NYSE:HUM - Free Report) by 118.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,881 shares of the insurance provider's stock after purchasing an additional 4,821 shares during the period. PDT Partners LLC's holdings in Humana were worth $2,253,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. FPC Investment Advisory Inc. purchased a new position in Humana during the 4th quarter valued at about $27,000. Centricity Wealth Management LLC purchased a new position in Humana during the fourth quarter valued at approximately $30,000. LFA Lugano Financial Advisors SA raised its stake in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after buying an additional 45 shares in the last quarter. OFI Invest Asset Management purchased a new stake in Humana during the fourth quarter worth $33,000. Finally, Transce3nd LLC bought a new stake in Humana during the 4th quarter valued at $38,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Analyst Ratings Changes

HUM has been the subject of a number of analyst reports. Piper Sandler upped their price objective on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Morgan Stanley decreased their price target on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 12th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research report on Thursday. Raymond James upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective for the company in a research note on Thursday. Finally, Truist Financial lifted their price target on shares of Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a report on Friday, April 11th. Eighteen analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $287.76.

Humana Stock Performance

Shares of NYSE HUM traded up $2.17 during trading on Friday, reaching $258.21. 1,740,020 shares of the company traded hands, compared to its average volume of 1,753,228. The stock has a market cap of $31.16 billion, a P/E ratio of 25.95, a PEG ratio of 2.05 and a beta of 0.49. The firm's fifty day simple moving average is $266.17 and its 200 day simple moving average is $270.63. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The company had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. During the same period last year, the business earned $7.23 earnings per share. Humana's quarterly revenue was up 8.4% on a year-over-year basis. As a group, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.